Leeds-based Radar Healthcare has acquired patient experience and outcomes platform Cemplicity, its second bolt-on acquisition in short order, as the Marlin Equity Partners-backed group builds out its healthcare quality and safety software. Financial terms were not disclosed.
Radar Healthcare supplies health and care organisations with tools for quality, risk, compliance, incident, audit and action management, alongside patient information and digital consent. Cemplicity adds a complementary layer: patient-reported experience measures, patient-reported outcome measures, real-time feedback, shared decision-making insight and post-care outcomes.
The rationale is data adjacency. Radar Healthcare captures the governance and improvement workflows inside a provider; Cemplicity captures what patients themselves report about their care. Combined, the two intend to connect the patient voice directly to the operational actions needed to respond, letting providers identify risks earlier and reduce avoidable harm.
The deal is the second in a run of acquisitions for the group. It follows the recent purchase of EIDO Healthcare, a provider of digital consent and patient information tools, and points to a buy-and-build strategy underwritten by Marlin Equity Partners. The US-headquartered technology investor took a stake in Radar Healthcare to support investment in the platform, its people and customer success, and is now funding inorganic expansion on top of organic growth.
Chief executive Edward Bellamy framed the transaction around shared purpose, saying Cemplicity's expertise in patient experience and reported outcomes "strongly complements" Radar Healthcare's quality, risk, compliance and improvement platform, and that together the businesses can help customers connect what patients experience with the workflows needed to act on it.
Blaik Wilson, chief executive of Cemplicity, said joining Radar Healthcare gives the business the chance to extend its impact and support more organisations in using patient-reported insight to improve care.
With terms undisclosed, the cap-table detail, including whether Cemplicity's shareholders took cash, a mix of cash and equity, or an earn-out, is not public. What is clear is the shape of the consolidation play: a private-equity-backed platform absorbing point solutions to broaden its footprint across a fragmented healthcare software market.
For customers, the combination promises a single supplier spanning consent, compliance, incident management and patient-reported outcomes rather than a patchwork of tools. For Marlin, it is a familiar template, using a core platform as an acquisition vehicle to build scale ahead of an eventual exit.
The pace matters. Two acquisitions in quick succession suggests Radar Healthcare has both an integration playbook and the capital to keep buying, and further bolt-ons would be consistent with the strategy now taking shape in Leeds.
*Original source: BusinessCloud
